Author

Kangbo Peng

Observed name: Kang-Bo Peng

Institution: Humanwell Healthcare Group (China)

Observed institutions: Hubei University of Chinese Medicine, Humanwell Healthcare Group (China)

ORCID: 0000-0003-1395-4826

Observed ORCID: 0000-0003-1395-4826

OpenAlex ID: A5111006356

Picroside II Inhibits Glycolysis and Migration in HepG2 Cells

2024 · Xia Lei, Si-Cheng Yang, et al. · Pharmacognosy Magazine · 2

Inhibition of Tumor Glycolysis by Umbelliferone and its Binding to Glycolytic Proteins

2023 · Kangbo Peng, Yingxiao Wang, et al. · Pharmacognosy Magazine · 1

Impatiens shenglanii exerts antithrombotic effects by inhibiting the PI3K/Akt/GSK3B signaling pathway and reprogramming arachidonic acid metabolism

2026 · Sini Wang, Huimin Zhou, et al. · Fitoterapia

Rhapontigenin Improves Non-alcoholic Fatty Liver Disease by Inducing Lipophagy Through the ACOX1 and mTOR/ULK1 Pathways

2023 · Ying-Xiao Wang, Xin-Ge Ke, et al. · Pharmacognosy Magazine

Works count: 4

Citation count: 3

H-index: 1

I10-index: